Sections
| Title |
|---|
| Table of Contents |
| 1 The Female Health Company |
| 2 The Female Health Company - Key Employees |
| 3 The Female Health Company - Key Employees Biographies |
| 4 The Female Health Company - Major Products and Services |
| 5 The Female Health Company - History |
| 6 The Female Health Company - Company Statement |
| 7 The Female Health Company - Locations and Subsidiaries |
| 7.1 The Female Health Company - Head Office |
| 7.2 The Female Health Company - Other Locations and Subsidiaries |
| 8 The Female Health Company - Business Analysis |
| 8.1 The Female Health Company - Company Overview |
| 8.2 The Female Health Company - Business Description |
| 9 The Female Health Company - SWOT Analysis |
| 9.1 The Female Health Company - SWOT Analysis - Overview |
| 9.2 The Female Health Company - Strengths |
| 9.2.1 Strength - US FDA approved FC2 |
| 9.2.2 Strength - Wide Distribution Network |
| 9.2.3 Strength - Strong Financial Performance |
| 9.3 The Female Health Company - Weaknesses |
| 9.3.1 Weakness - Limited Customer Base |
| 9.3.2 Weakness - Dependence on a Single Product |
| 9.4 The Female Health Company - Opportunities |
| 9.4.1 Opportunity - Online Retailing |
| 9.4.2 Opportunity - Growth in Condom Market |
| 9.4.3 Opportunity - New Contracts |
| 9.5 The Female Health Company - Threats |
| 9.5.1 Threat - Foreign Exchange Risks |
| 9.5.2 Threat - Stringent Regulations |
| 9.5.3 Threat - Intense Competition |
| 10 The Female Health Company - Company Financial Analysis |
| 10.1 The Female Health Company - Five Year Snapshot: Overview of Financial and Operational Performance Indicators |
| 11 The Female Health Company - Interim ratios |
| 11.1.1 The Female Health Company - Financial ratios: Capital Market Ratios |
| 11.2 The Female Health Company - Financial Performance and Ratio Charts |
| 11.2.1 The Female Health Company - Revenue and Operating margin |
| 11.2.2 The Female Health Company - Asset and Liabilities |
| 11.2.3 The Female Health Company - Operational Efficiency |
| 11.2.4 The Female Health Company - Valuation |
| 11.3 The Female Health Company - Competitive Benchmarking |
| 11.3.1 The Female Health Company - Market Capitalization |
| 11.3.2 The Female Health Company - Efficiency |
| 11.3.3 The Female Health Company - Valuation |
| 11.3.4 The Female Health Company - Turnover: Inventory and Asset |
| 12 The Female Health Company - Mergers & Acquisitions and Partnerships |
| 12.1 The Female Health Company - M&A and Partnerships Strategy |
| 13 The Female Health Company - Recent Developments |
| 14 Appendix |
| 14.1 Methodology |
| 14.2 The Female Health Company - Ratio Definitions |
| 14.3 Disclaimer |
| List of Tables |
| Table 1: The Female Health Company - Key Employees |
| Table 2: The Female Health Company - Key Employees Biographies |
| Table 3: The Female Health Company - Major Products and Services |
| Table 4: The Female Health Company - History |
| Table 5: The Female Health Company - Subsidiaries |
| Table 6: The Female Health Company - Locations |
| Table 7: The Female Health Company - Annual ratios |
| Table 8: The Female Health Company - Interim ratios |
| Table 9: The Female Health Company - Capital Market Ratios |
| List of Figures |
| Figure 1: The Female Health Company - Revenue and Operating Profit |
| Figure 2: The Female Health Company - Asset and Liabilities |
| Figure 3: The Female Health Company - Operational Efficiency |
| Figure 4: The Female Health Company - Valuation |
| Figure 5: The Female Health Company - Market Capitalization |
| Figure 6: The Female Health Company - Efficiency |
| Figure 7: The Female Health Company - Valuation |
| Figure 8: The Female Health Company - Turnover: Inventory and Asset |